Dr Ian Button MBBS FRACP is a general cardiologist with special interests in interventional cardiology, hypertension and coronary CT scanning. He joined SA Heart in 1998.
Dr Button graduated MBBS from the University of Adelaide where he was a winner of the Alex Ramsay Prize. He completed his cardiology training at The Queen Elizabeth Hospital in 1993 and was awarded a Cardiac Society of Australia and New Zealand Travelling Scholarship in the same year. He was admitted as a Fellow of the Royal Australasian College of Physicians in 1994.
1. Button IK: Deaths from asthma. Asthma News, January 1986.
2. Button IK, Horowitz JD, Morris RG: Carbamazepine induces Perhexiline metabolism: implications for cytochrome P450 activity. (Submitted for publication – Postgraduate Medical Journal).
3. Button IK, Davies HR, Zietz CK, Wuttke RD, Horowitz JD: Adverse reactions to Perhexiline during short and long term therapy. Aust NZ J Med 1993;25:599.
4. Horowitz JD, Button IK, Wing L: Is Perhexiline essential for the optimal management of angina pectoris. Aust NZ J Med 1995:25:111-113.
5. Unger SA, Button IK, Wuttke RD, Hii JTY: Outcomes of empiric antiarrhythmic drug therapy for ventricular tachyarrhythmias: a comparison of Amiodarone and Sotalol. Accepted for publication. Braz Latin Am J Card Pacing.
Participation in clinical trials
1. ISIS-2: International studies of infarct survival.
2. GUSTO: Global utilisation of streptokinase and tPA for occluded arteries.
3. MK 383 (PRISM)
6. OPUS TIMI 16
7. ASSENT II
8. GUSTO III
9. Medtronic Lead Trial
1. 'Adverse Reactions to Perhexiline during Short and Long-term Therapy'.
This study was presented at the Cardiac Society of Australia and New Zealand scientific meeting in Christchurch in 1993, the “Research Day”, the Queen Elizabeth Hospital, Adelaide, and at the South Australian “Advanced Trainee Scientific Meeting” at the Royal Adelaide Hospital in November 1993.
2. 'Outcomes of Empiric Antiarrhythmic Drug Therapy for Ventricular Tachycardia/Ventricular Fibrillation: A Comparison of Amiodarone and Sotalol'.
This was presented at the Cardiac Society of Australia and New Zealand scientific meeting 1995 and at the X World Symposium on Cardiac Pacing and Electrophysiology in Buenos Aires, October 1995.